TickerFactsScreenerDevelopers

SUTRO BIOPHARMA, INC. (STRO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: $1.36M2017: -$19.27M2018: -$37.22M2019: -$55.47M2020: -$71.06M2021: -$98.52M2022: -$128.94M2023: -$89.28M2024: -$238.45M2025: -$158.37M-$158.37M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$158.37M+33.6%
2024-$238.45M-167.1%
2023-$89.28M+30.8%
2022-$128.94M-30.9%
2021-$98.52M-38.7%
2020-$71.06M-28.1%
2019-$55.47M-49.0%
2018-$37.22M-93.1%
2017-$19.27M-1512.9%
2016$1.36M—